The impact of smoking on adherence to treatment for latent tuberculosis infection
2006

Impact of Smoking on Treatment Adherence for Latent Tuberculosis

Sample size: 320 publication Evidence: moderate

Author Information

Author(s): Mélanie Lavigne, Isabelle Rocher, Colin Steensma, Paul Brassard

Primary Institution: McGill University Health Center

Hypothesis

Smokers with latent tuberculosis infection (LTBI) are less likely to comply with their LTBI treatment regimen.

Conclusion

Males and smokers need to have extra supervision to ensure compliance with LTBI treatment.

Supporting Evidence

  • 320 patients were recruited, and 302 (94%) completed the questionnaire.
  • Smoking prevalence was 21%.
  • 72% of patients were adherent to LTBI treatment.
  • Women were more likely to adhere to treatment than men.

Takeaway

Smoking can make it harder for people to stick to their medicine for tuberculosis, especially for men.

Methodology

A convenience sample of patients undergoing treatment for LTBI completed a questionnaire on smoking status and adherence was assessed through pill counts and self-reports.

Potential Biases

Social desirability bias may have led to underreporting of smoking prevalence.

Limitations

Self-reported smoking status may have been biased, and factors like economic status and language barriers were not fully explored.

Participant Demographics

320 patients, mean age 35.5 years, 87% foreign born, 21% smokers.

Statistical Information

P-Value

p<0.001

Confidence Interval

95% CI: 1.2–3.3

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2458-6-66

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication